Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 July 2005 : Case report  

Is restoring regenerative potential a way to prevent anthracycline cardiotoxicity? A hypothesis.

Arnold Koller, Christian Haid

Med Sci Monit 2005; 11(7): HY12-23 :: ID: 16857

Abstract

Anthracycline-induced cardiotoxic effects are a serious problem among young patients who survive childhood cancer and there is an urgent need to avoid such effects. It is generally accepted that the only effective way to do this is to prevent cardiac injury during chemotherapy. There are several possible ways to do this, though questions remain. Evidence suggests the existence of a resident population of self-renewing cardiac stem cells capable of contributing to heart repair. Cardiac stem cells have an intrinsically poor regenerative response to heart injury. However, recent results point to ways to enhance the formation of cardiac precursor cells necessary for regeneration after injury. Moreover, the results of a recent study demonstrated that activation of the Notch signaling pathway, well characterized for its role in myogenesis and tissue formation during embryogenesis, restores impaired regenerative potential of skeletal muscle by activating resident precursor cells (satellite cells), which have a markedly impaired propensity to proliferate and to produce the myoblasts necessary for muscle regeneration. Based on these findings, and because the mechanisms behind the cardiotoxic effects of anthracyclines are not fully understood and current ways to avoid anthracycline-induced cardiotoxic effects have limitations, we hypothesize herein that an attractive way to avoid these effects may be to promote repair and regeneration, as opposed to prevent injury (e.g. by dexrazoxane).

Keywords: Anthracyclines - adverse effects, Anthracyclines - therapeutic use, Heart Diseases - chemically induced, Heart Diseases - prevention & control, Myoblasts, Cardiac - drug effects, Myoblasts, Cardiac - metabolism, Myoblasts, Cardiac - physiology, Anthracyclines - therapeutic use, Antineoplastic Agents - therapeutic use, Heart Diseases - prevention & control, Membrane Proteins - metabolism, Myoblasts, Cardiac - physiology, Myocardium - pathology, Receptors, Notch, Regeneration, Stem Cells - physiology

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750